Patient centricity on trial

Patient centricity on trial

CLINICAL TRIALS ARE BROKEN AND ONLY PATIENTS CAN HELP US FIX THEM. IF WE LET THEM.

“Patient centricity is a misused buzzword to signpost all manner of token efforts, but the real winners will be those who embrace it throughout their organisation. Not just because it’s the right thing to do, but because it is the only way to fix a broken model.” Mark Evans, Managing Director of Havas Lynx Faze.

Today, 40 million patients are needed for over 300,00 clinical trials, worldwide. The 2019 Havas lynx Faze white paper explores how patients and new companies are bringing the patient experience front and centre in clinical trials, to tackle some of the huge systematic problems the industry is facing. From protocol design to consent, recruitment and retention, those who take the time to understand patient experience of every clinical trial touchpoint are those who are building successful clinical trials.

To read our latest white paper visit patientcentricityontrial.com